Study of Safety and Immunogenicity of BVRS-GamVac-Combi
Conditions
- MERS (Middle East Respiratory Syndrome)
- MERS
Interventions
- DRUG: BVRS-GamVac-Combi
- OTHER: placebo
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Collaborators